Le Lézard
Classified in: Health
Subjects: PDT, TDS

Qfix Releases New Solution to Improve Patient Transport and Brachytherapy Workflows


AVONDALE, Pa., Oct. 19, 2018 /PRNewswire/ -- Qfix announces the launch of the new Brachytherapy Transfer Device for the Symphonytm Patient Transport System. The Symphonytm System improves workflow efficiencies and throughput by seamlessly aiding in the setup, positioning and transfer of patients for procedures involving imaging and Brachytherapy treatments.

Use of the Symphonytm System reduces the potential for back injuries during patient transfers and requires fewer staff members than alternate methods. "Symphony provides a simple way to safely improve workflow efficiencies and throughput, enabling centers to treat more patients during a typical day of treatment," stated Dan Coppens, CEO and Chief Technology Officer.

The Symphonytm System and all available Transfer Devices will be on display at the Qfix booth #1913 during the American Society for Radiation Oncology (ASTRO), October 21-24, 2018.

About Qfix

Qfix is a world leader in radiotherapy dedicated to helping medical professionals provide the best patient care with the world's finest positioning devices designed to enhance the probability of positive patient outcomes. For more information, visit www.Qfix.com.

SOURCE Qfix


These press releases may also interest you

at 21:27
Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae Enters into Agreement with Labcorp for Sale of Business
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
/C O R R E C T I O N -- Valcare Medical/
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

at 19:59
Genomma Lab Internacional Announces Results for the First Quarter 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 19:46
South Florida City Launches Groundbreaking Initiative to Reduce Gun Violence and Foster Peace
Although gun violence is down by 12%, gun-related homicide is up by 44%. Therefore, the City of Lauderhill is announcing a pivotal strategy to reduce gun violence and promote peace among its 75,000 residents. This plan highlights Lauderhill's...

More news about Health...


News published on and distributed by: